NON SMALL CELL LUNG CARCINOMA
Clinical trials for NON SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets hard-to-treat KRAS cancers
Disease control OngoingThis study tests a new drug called JDQ443, given with other treatments, for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to see if the combination is safe and can shrink or control the cancer. About 74 adults with lung or col…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 18:27 UTC
-
New drug combo shows promise against tough lung cancer
Disease control OngoingThis study tests an experimental drug called AZD2936 in people with advanced or metastatic non-small cell lung cancer (NSCLC). The drug is designed to help the immune system fight cancer by blocking two targets (TIGIT and PD-1). The main goals are to check safety and see if the d…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Vitamin c boost: could High-Dose ascorbate improve lung cancer treatment?
Disease control OngoingThis phase 2 trial tests whether adding high-dose vitamin C (ascorbate) to standard chemotherapy and radiation helps control non-small cell lung cancer. 43 participants received the combination therapy. The study measures tumor response and how long it takes for the cancer to pro…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Joseph J. Cullen, MD, FACS • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Two-drug attack targets hard-to-treat cancers
Disease control OngoingThis early-phase study tests a combination of two drugs—trastuzumab deruxtecan and pembrolizumab—in people with advanced breast or non-small cell lung cancer that has spread. The goal is to find the safest dose and see if the combo shrinks tumors. About 115 adults with HER2-posit…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Experimental vaccine combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tested a new cancer vaccine (p53MVA) combined with the immunotherapy drug pembrolizumab in 11 adults with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the combination is safe and can help the immune system re…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New online therapy aims to ease emotional burden for women fighting lung cancer
Symptom relief OngoingThis study tests an online program designed to improve social well-being and emotional support for women with non-small cell lung cancer. About 70 women currently receiving treatment will practice mindfulness, compassion, and emotional processing techniques. The goal is to see if…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC